v3.26.3
Condensed Consolidated Statements of Stockholders Equity - USD ($)
$ in Thousands
Total
Mantle Therapeutics Inc. [Member]
2023 ESPP [Member]
May 2025 Private Placement [Member]
Leerink At The Market Sales Agreement [Member]
Common Stock [Member]
Common Stock [Member]
Mantle Therapeutics Inc. [Member]
Common Stock [Member]
2023 ESPP [Member]
Common Stock [Member]
May 2025 Private Placement [Member]
Common Stock [Member]
Leerink At The Market Sales Agreement [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Mantle Therapeutics Inc. [Member]
Additional Paid-in Capital [Member]
2023 ESPP [Member]
Additional Paid-in Capital [Member]
May 2025 Private Placement [Member]
Additional Paid-in Capital [Member]
Leerink At The Market Sales Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Balance, shares at Dec. 31, 2024           33,071,261                        
Balance, value at Dec. 31, 2024 $ 116,842         $ 3         $ (17) $ 397,132         $ (103) $ (280,173)
Issuance of common stock upon vesting and settlement of restricted stock units, shares           52,446                        
Issuance of common stock, Shares               65,342                    
Issuance of common stock, Value     $ 170                     $ 170        
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares           2,816                        
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value 13                     13            
Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities 49                               49  
Stock-based compensation expense 3,697                     3,697            
Net loss (32,656)                                 (32,656)
Balance, shares at Mar. 31, 2025           33,191,865                        
Balance, value at Mar. 31, 2025 88,115         $ 3         (17) 401,012         (54) (312,829)
Balance, shares at Dec. 31, 2024           33,071,261                        
Balance, value at Dec. 31, 2024 116,842         $ 3         (17) 397,132         (103) (280,173)
Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities 192                                  
Net loss (79,042)                                  
Balance, shares at Sep. 30, 2025           54,934,275                        
Balance, value at Sep. 30, 2025 120,831         $ 5         (17) 479,969         89 (359,215)
Balance, shares at Dec. 31, 2024           33,071,261                        
Balance, value at Dec. 31, 2024 116,842         $ 3         (17) 397,132         (103) (280,173)
Net loss (100,000)                                  
Balance, shares at Dec. 31, 2025           73,001,350                        
Balance, value at Dec. 31, 2025 246,669         $ 7         (17) 626,625         188 (380,134)
Balance, shares at Mar. 31, 2025           33,191,865                        
Balance, value at Mar. 31, 2025 88,115         $ 3         (17) 401,012         (54) (312,829)
Issuance of common stock upon vesting and settlement of restricted stock units, shares           14,097                        
Issuance of common stock, Shares                 20,790,120                  
Issuance of common stock, Value       $ 73,082         $ 2           $ 73,080      
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares           2,410                        
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value 12                     12            
Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities 41                               41  
Stock-based compensation expense 3,071                     3,071            
Net loss (26,103)                                 (26,103)
Balance, shares at Jun. 30, 2025           53,998,492                        
Balance, value at Jun. 30, 2025 138,218         $ 5         (17) 477,175         (13) (338,932)
Issuance of common stock upon vesting and settlement of restricted stock units, shares           20,466                        
Issuance of common stock, Shares               37,495                    
Issuance of common stock, Value     101                     101        
Exercise of stock options, shares           9,000                        
Exercise of stock options, value 34                     34            
Issuance of common stock upon exercise of pre-funded warrants, shares           867,302                        
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares           1,520                        
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value 8                     8            
Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities 102                               102  
Stock-based compensation expense 2,651                     2,651            
Net loss (20,283)                                 (20,283)
Balance, shares at Sep. 30, 2025           54,934,275                        
Balance, value at Sep. 30, 2025 120,831         $ 5         (17) 479,969         89 (359,215)
Balance, shares at Dec. 31, 2025           73,001,350                        
Balance, value at Dec. 31, 2025 246,669         $ 7         (17) 626,625         188 (380,134)
Issuance of common stock upon vesting and settlement of restricted stock units, shares           163,310                        
Issuance of common stock, Shares           867,302   52,285                    
Issuance of common stock, Value 2,446   143                 2,446   143        
Exercise of stock options, shares           2,400                        
Exercise of stock options, value 9                     9            
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares           90                        
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value 1                     1            
Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities (330)                               (330)  
Stock-based compensation expense 2,755                     2,755            
Net loss (20,196)                                 (20,196)
Balance, shares at Mar. 31, 2026           74,086,737                        
Balance, value at Mar. 31, 2026 231,497         $ 7         (17) 631,979         (142) (400,330)
Balance, shares at Dec. 31, 2025           73,001,350                        
Balance, value at Dec. 31, 2025 246,669         $ 7         (17) 626,625         188 (380,134)
Issuance of common stock, Shares                   7,533,881                
Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities (653)                                  
Net loss (84,363)                                  
Balance, shares at Sep. 30, 2026           82,785,830                        
Balance, value at Sep. 30, 2026 216,691         $ 8         (17) 681,662         (465) (464,497)
Balance, shares at Mar. 31, 2026           74,086,737                        
Balance, value at Mar. 31, 2026 231,497         $ 7         (17) 631,979         (142) (400,330)
Issuance of common stock upon vesting and settlement of restricted stock units, shares           47,211                        
Issuance of common stock, Shares                   4,424,778                
Issuance of common stock, Value         $ 23,576         $ 1           $ 23,575    
Exercise of stock options, shares           63,818                        
Exercise of stock options, value 320                     320            
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares           60                        
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value 1                     1            
Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities (156)                               (156)  
Stock-based compensation expense 5,690                     5,690            
Net loss (25,867)                                 (25,867)
Balance, shares at Jun. 30, 2026           78,622,604                        
Balance, value at Jun. 30, 2026 235,061         $ 8         (17) 661,565         (298) (426,197)
Issuance of common stock upon vesting and settlement of restricted stock units and performance restricted stock units, shares           362,008                        
Issuance of common stock, Shares               59,148   3,109,103                
Issuance of common stock, Value     $ 163   $ 14,077                 $ 163   $ 14,077    
Issuance of common stock aquisition, Shares             632,907                      
Issuance of common stock acquisition   $ 2,165                     $ 2,165          
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares           60                        
Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities (167)                               (167)  
Stock-based compensation expense 3,692                     3,692            
Net loss (38,300)                                 (38,300)
Balance, shares at Sep. 30, 2026           82,785,830                        
Balance, value at Sep. 30, 2026 $ 216,691         $ 8         $ (17) $ 681,662         $ (465) $ (464,497)